Background Intrahepatic recurrence of hepatocellular carcinoma (HCC) following resection
is common. However, no current consensus guidelines exist to inform management …

There is controversy concerning whether radiofrequency ablation (RFA) or surgical
resection (SR) is a better treatment option for recurrent HCC after resection. In Kaohsiung …

Background This study aims to assess if radiofrequency ablation (RFA) has any oncological
superiority over transarterial chemoembolization (TACE) on post-hepatectomy recurrence …

Aim: To compare the overall survival (OS) in patients without recurrent hepatocellular
carcinoma (HCC) after initial radiofrequency ablation (RFA) and in those with recurrence …

Hepatocellular carcinoma (HCC) is the most common primary liver cancer and is the fifth
leading cause of cancer death worldwide and the third leading cause of all diseases …

Background Recurrent hepatocellular carcinoma (RHCC) is commonly treated with
transcatheter arterial chemoembolization (TACE) combined with microwave ablation (MWA) …

Background Repeat hepatectomy and radiofrequency ablation (RFA) are widely used to
treat early recurrent hepatocellular carcinoma (RHCC) located in the subcapsular region …

Objective The optimal treatment strategy for patients with recurrent hepatocellular carcinoma
(HCC) remains unclear. This study was designed to investigate the outcomes of salvage …

Aim: To assess the efficacy and safety of radiofrequency ablation (RFA) combined with
transarterial chemoembolization (TACE) in recurrent hepatocellular carcinoma (HCC) after …

Background The purpose of this study was to compare the efficacy and safety of transarterial
chemoembolization (TACE) in combination with radiofrequency ablation (RFA)(TACE-RFA) …